$heff's $tation of $tocks & $olid DD

[nywest329]

AMRN - what a day for trading this stock. Amarin Reports Fourth Quarter and Year-End 2011 Financial Results and Provides Update on Operations
Conference Call Set for 4:30 p.m. EST Today
GlobeNewswirePress Release: Amarin Corporation plc – 41 minutes ago


RELATED QUOTES
Symbol Price Change
AMRN 7.75 -0.98

BEDMINSTER, N.J. and DUBLIN, Ireland, Feb. 29, 2012 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN - News), a late-stage biopharmaceutical company focused on cardiovascular disease, today announced financial results for the quarter and year ended December 31, 2011 and provided an update on company operations.

Key Amarin accomplishments since the quarter ended September 30, 2011 include:

* Acceptance of AMR101 New Drug Application (NDA) by the U.S. Food and Drug Administration (FDA) and FDA assignment of Prescription Drug User Fee Act (PDUFA) date of July 26, 2012
* Strengthened balance sheet through successful completion of a $150M exchangeable note offering
* Commenced patient enrollment and dosing in the REDUCE-IT cardiovascular outcomes study
* Broadened management team with the addition of a General Counsel and a President of R&D

"In 2011, Amarin made important progress toward the development of, and commercial preparedness for, our lead product candidate, AMR101," said Joseph Zakrzewski, Chairman and Chief Executive Officer of Amarin. "In 2012 we are working vigorously to build on this progress and maximize the value of AMR101 as we advance toward the PDUFA date."

http://finance.yahoo.com/news/amarin-reports-fourth-quarter-end-210100913.html